These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6214989)

  • 1. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.
    Srinivasan S; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
    Scheld WM; Spyker DA; Donowitz GR; Bolton WK; Sande MA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):613-9. PubMed ID: 6454387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.
    Polk RE; Kline BJ; Markowitz SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):576-9. PubMed ID: 6459759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam--absorption, excretion, distribution, and metabolism.
    Shimada J; Ueda Y
    Rev Infect Dis; 1982; 4 Suppl():S569-80. PubMed ID: 6218568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion.
    Polk R; Hume A; Kline BJ; Cardea J
    Clin Orthop Relat Res; 1983; (177):216-21. PubMed ID: 6222858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of moxalactam in patients with malignant disease.
    Estey EH; Weaver SS; Ho DH; Bodey GP
    Antimicrob Agents Chemother; 1981 Apr; 19(4):639-44. PubMed ID: 6454389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers.
    Parsons JN; Romano JM; Levison ME
    Antimicrob Agents Chemother; 1980 Feb; 17(2):226-8. PubMed ID: 6446259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.
    Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB; McCracken GH; Threlkeld N; Thomas ML
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of moxalactam in patients with renal insufficiency.
    Lam M; Manion CV; Czerwinski AW
    Antimicrob Agents Chemother; 1981 Mar; 19(3):461-4. PubMed ID: 6454383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
    Srinivasan S; Neu HC
    Antimicrob Agents Chemother; 1981 Sep; 20(3):398-400. PubMed ID: 6458236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
    Neu HC
    Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxalactam pharmacokinetics in children.
    Romagnoli MF; Flynn K; Siber GR; Goldmann DA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):47-50. PubMed ID: 6214997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of probenecid on the pharmacokinetics of moxalactam.
    DeSante KA; Israel KS; Brier GL; Wolny JD; Hatcher BL
    Antimicrob Agents Chemother; 1982 Jan; 21(1):58-61. PubMed ID: 6211135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of moxalactam and cefazolin into atrial appendage after simultaneous intramuscular or intravenous administration.
    Polk RE; Smith JE; Ducey K; Lower RR
    Antimicrob Agents Chemother; 1982 Aug; 22(2):201-3. PubMed ID: 6927281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.
    Wise R; Baker S; Livingston R
    Antimicrob Agents Chemother; 1980 Sep; 18(3):369-71. PubMed ID: 6252833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of moxalactam in adults].
    Humbert G; Leroy A; Fillastre JP
    Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxalactam pharmacokinetics during hemodialysis.
    Aronoff GR; Sloan RS; Mong SA; Luft FC; Kleit SA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):575-7. PubMed ID: 6454386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.